Achieve life sciences to announce third quarter 2021 financial results and host conference call and webcast on november 9, 2021

Seattle, wa/ vancouver, bc , oct. 26, 2021 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it will report its third-quarter 2021 financial results and provide an update on the cytisinicline development program on tuesday, november 9, 2021, at 4:30 pm est.
ACHV Ratings Summary
ACHV Quant Ranking